Harris Todd's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Mar 31, 2023
- Accession no.
- 0001209191-23-021947
- Filed
- Mar 31, 2023
- Trade date
- Mar 29-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $69.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harris ToddCIK 0001711463 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 | Common Stock | MOption exerciseAcquired | +1,420 | $2.25 | +$3,195 | 1,702,696 | Direct | |
| Mar 29, 2023 | Common Stock | SSaleDisposed | −1,420 | $16.18 | −$22,975.6 | 1,701,276 | Direct | |
| Mar 30, 2023 | Common Stock | MOption exerciseAcquired | +2,407 | $2.25 | +$5,415.75 | 1,703,683 | Direct | |
| Mar 30, 2023 | Common Stock | SSaleDisposed | −2,407 | $16.02 | −$38,560.14 | 1,701,276 | Direct | |
| Mar 31, 2023 | Common Stock | MOption exerciseAcquired | +500 | $2.25 | +$1,125 | 1,701,776 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −500 | $16.05 | −$8,025 | 1,701,276 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 | Common Stock | MOption exerciseDisposed | −1,420 | $0.00 | $0 | 402,444 | Direct | |
| Mar 30, 2023 | Common Stock | MOption exerciseDisposed | −2,407 | $0.00 | $0 | 400,037 | Direct | |
| Mar 31, 2023 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 399,537 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.